Traders Buy Davita (DVA) on Weakness

Investors bought shares of Davita Inc (NYSE:DVA) on weakness during trading on Friday. $39.96 million flowed into the stock on the tick-up and $15.26 million flowed out of the stock on the tick-down, for a money net flow of $24.70 million into the stock. Of all stocks tracked, Davita had the 15th highest net in-flow for the day. Davita traded down ($0.06) for the day and closed at $65.94

Several equities analysts recently commented on the stock. Bank of America reiterated a “buy” rating and set a $92.00 target price (up from $85.00) on shares of Davita in a research note on Thursday, January 11th. JPMorgan Chase upped their target price on shares of Davita from $4.90 to $84.00 and gave the company a “strong-buy” rating in a research note on Thursday, December 7th. SunTrust Banks set a $70.00 target price on shares of Davita and gave the company a “hold” rating in a research note on Thursday, December 7th. KeyCorp reiterated a “hold” rating on shares of Davita in a research note on Wednesday, December 6th. Finally, Robert W. Baird upgraded shares of Davita from a “neutral” rating to an “outperform” rating and upped their target price for the company from $63.00 to $82.00 in a research note on Tuesday, December 12th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, four have issued a buy rating and two have given a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $79.30.

How to Become a New Pot Stock Millionaire

The company has a market cap of $12,001.08, a PE ratio of 19.17, a price-to-earnings-growth ratio of 0.95 and a beta of 1.03. The company has a debt-to-equity ratio of 1.87, a quick ratio of 2.82 and a current ratio of 2.88.

Davita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.02). Davita had a net margin of 4.65% and a return on equity of 12.86%. The business had revenue of $2.78 billion during the quarter, compared to analyst estimates of $3.90 billion. During the same quarter in the prior year, the company posted $0.98 EPS. equities research analysts forecast that Davita Inc will post 4.15 earnings per share for the current year.

In other news, insider James K. Hilger sold 3,572 shares of the stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the completion of the transaction, the insider now owns 33,649 shares in the company, valued at approximately $2,656,588.55. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 2.10% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Millennium Management LLC raised its stake in shares of Davita by 239.9% in the 4th quarter. Millennium Management LLC now owns 2,024,308 shares of the company’s stock valued at $146,256,000 after buying an additional 1,428,810 shares in the last quarter. OppenheimerFunds Inc. grew its holdings in shares of Davita by 5,292.6% in the 4th quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock worth $135,391,000 after purchasing an additional 1,839,168 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Davita by 1.0% in the 4th quarter. Geode Capital Management LLC now owns 1,609,652 shares of the company’s stock worth $116,051,000 after purchasing an additional 16,017 shares during the last quarter. Bridger Management LLC bought a new stake in shares of Davita in the 4th quarter worth about $52,339,000. Finally, First Trust Advisors LP grew its holdings in shares of Davita by 5.1% in the 4th quarter. First Trust Advisors LP now owns 650,039 shares of the company’s stock worth $46,965,000 after purchasing an additional 31,743 shares during the last quarter. Institutional investors own 85.80% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Traders Buy Davita (DVA) on Weakness” was originally posted by WKRB News and is owned by of WKRB News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.wkrb13.com/2018/04/01/traders-buy-davita-dva-on-weakness.html.

About Davita

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply